Ototoxicity Terminated Phase 4 Trials for Cysteine (DB00151)

Also known as: Auditory toxicity / Ototoxicity (disorder)

IndicationStatusPhase
DBCOND0008838 (Ototoxicity)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04226456Intratympanic Administration of N-acetylcysteine for Protection of Cisplatin-induced OtotoxicityPrevention